Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The OMAGE (Optimization of Medication in AGEd) Transitional Care-Pathway: Impact on Readmissions

NCT02657642 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT02657642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02657642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The OMAGE (Optimization of Medication in AGEd) Transitional Care-Pathway: Impact on Readmissions
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2018
Enrollment
484 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ageing